P2Y12 Platelet Inhibitor [EPC]

P2Y12 Platelet Inhibitor [EPC] was reported 119949 times

Drugs of the P2Y12 Platelet Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VASCULAR STENT THROMBOSIS 1236 0.6068
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 89 0.4972
2 VASCULAR STENT OCCLUSION 193 0.4789
3 CORONARY REVASCULARISATION 67 0.4241
4 VASCULAR STENT STENOSIS 137 0.3254
5 SPINAL EPIDURAL HAEMATOMA 139 0.2360
6 INSULIN AUTOIMMUNE SYNDROME 82 0.2297
7 CORONARY ARTERY RESTENOSIS 116 0.1940
8 THROMBOSIS IN DEVICE 630 0.1920
9 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1272 0.1437
10 RESPIRATORY TRACT HAEMORRHAGE 83 0.1390
11 VASCULAR PSEUDOANEURYSM 214 0.1228
12 CORONARY ARTERY THROMBOSIS 207 0.1026
13 CORONARY ARTERY DISSECTION 85 0.0990
14 ARTERIAL HAEMORRHAGE 112 0.0980
15 CORONARY ARTERY STENOSIS 483 0.0959
16 ARTERIAL STENOSIS 79 0.0901
17 SINUS ARREST 137 0.0873
18 RETROPERITONEAL HAEMATOMA 192 0.0868
19 EXTRADURAL HAEMATOMA 114 0.0862
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 124 0.0850
21 ACQUIRED HAEMOPHILIA 85 0.0848
22 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 89 0.0838
23 BLOOD LOSS ANAEMIA 186 0.0820
24 HAEMATOMA MUSCLE 98 0.0817
25 CAROTID ARTERIOSCLEROSIS 84 0.0814
26 BLEEDING TIME PROLONGED 95 0.0786
27 HYPERPARATHYROIDISM SECONDARY 195 0.0778
28 ANGINA UNSTABLE 504 0.0775
29 CARDIAC VENTRICULAR THROMBOSIS 100 0.0775
30 CORONARY ARTERY OCCLUSION 1038 0.0756
31 PERICARDIAL HAEMORRHAGE 159 0.0726
32 ACUTE MYOCARDIAL INFARCTION 2114 0.0716
33 NEPHROGENIC ANAEMIA 331 0.0714
34 RETROPERITONEAL HAEMORRHAGE 176 0.0713
35 MYOGLOBIN BLOOD INCREASED 109 0.0712
36 PERIPHERAL ARTERY OCCLUSION 99 0.0704
37 CARDIAC ANEURYSM 66 0.0665
38 ACUTE CORONARY SYNDROME 545 0.0657
39 MELAENA 1431 0.0650
40 HAEMORRHAGIC TRANSFORMATION STROKE 96 0.0637
41 SYSTOLIC DYSFUNCTION 67 0.0636
42 SUBDURAL HAEMORRHAGE 174 0.0635
43 OESOPHAGEAL SPASM 117 0.0634
44 INTRAVENTRICULAR HAEMORRHAGE 155 0.0622
45 ABDOMINAL WALL HAEMATOMA 117 0.0599
46 INTERMITTENT CLAUDICATION 93 0.0586
47 ANGIOPLASTY 87 0.0583
48 AORTIC VALVE STENOSIS 103 0.0577
49 REBOUND ACID HYPERSECRETION 173 0.0571
50 PRODUCT MONITORING ERROR 81 0.0561
51 MALLORY-WEISS SYNDROME 71 0.0559
52 UPPER GASTROINTESTINAL HAEMORRHAGE 941 0.0559
53 KOUNIS SYNDROME 127 0.0559
54 DUODENAL ULCER HAEMORRHAGE 160 0.0559
55 VASCULAR OCCLUSION 118 0.0558
56 SUBDURAL HAEMATOMA 788 0.0550
57 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 77 0.0548
58 CAROTID ARTERY STENOSIS 189 0.0541
59 BRAIN NATRIURETIC PEPTIDE INCREASED 166 0.0538
60 ANGINA PECTORIS 1517 0.0529
61 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 174 0.0525
62 DIVERTICULUM INTESTINAL HAEMORRHAGIC 118 0.0524
63 MICROCYTIC ANAEMIA 109 0.0524
64 ARTERIAL OCCLUSIVE DISEASE 410 0.0521
65 SUBARACHNOID HAEMORRHAGE 519 0.0509
66 HAEMORRHAGE INTRACRANIAL 756 0.0505
67 SPLENIC RUPTURE 83 0.0505
68 CEREBELLAR HAEMORRHAGE 72 0.0503
69 LOWER GASTROINTESTINAL HAEMORRHAGE 370 0.0500
70 SHOCK HAEMORRHAGIC 406 0.0498
71 POST PROCEDURAL HAEMATOMA 82 0.0486
72 PROCEDURAL HAEMORRHAGE 190 0.0485
73 VENOUS OCCLUSION 88 0.0484
74 LABELLED DRUG-DRUG INTERACTION ISSUE 69 0.0477
75 SYSTEMIC INFECTION 79 0.0476
76 DYSPNOEA AT REST 137 0.0472
77 INFARCTION 323 0.0472
78 NONINFECTIVE GINGIVITIS 68 0.0469
79 STENOSIS 87 0.0463
80 CEREBRAL HAEMATOMA 153 0.0455
81 GASTRITIS EROSIVE 211 0.0452
82 NORMOCYTIC ANAEMIA 66 0.0449
83 STENT PLACEMENT 361 0.0447
84 CARDIAC TAMPONADE 212 0.0446
85 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 182 0.0445
86 CORONARY ARTERIAL STENT INSERTION 223 0.0439
87 PULMONARY ALVEOLAR HAEMORRHAGE 242 0.0431
88 OCCULT BLOOD POSITIVE 84 0.0427
89 VENTRICULAR HYPOKINESIA 134 0.0417
90 ORTHOPNOEA 130 0.0408
91 ISCHAEMIC CARDIOMYOPATHY 124 0.0404
92 HAEMATOMA 1036 0.0399
93 HAEMATEMESIS 1010 0.0398
94 GASTRIC HAEMORRHAGE 458 0.0398
95 THROMBOTIC THROMBOCYTOPENIC PURPURA 140 0.0397
96 HAEMOTHORAX 115 0.0396
97 HAEMORRHAGIC DIATHESIS 141 0.0396
98 TROPONIN INCREASED 301 0.0395
99 CARDIAC FAILURE CHRONIC 167 0.0391
100 SMALL INTESTINAL HAEMORRHAGE 78 0.0387
101 BRAIN HERNIATION 114 0.0381
102 CORONARY ARTERY DISEASE 1148 0.0379
103 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 67 0.0376
104 RHABDOMYOLYSIS 1546 0.0370
105 CEREBRAL HAEMORRHAGE 1326 0.0370
106 DIASTOLIC DYSFUNCTION 114 0.0369
107 CHOLESTATIC LIVER INJURY 82 0.0368
108 DUODENAL ULCER 258 0.0365
109 END STAGE RENAL DISEASE 655 0.0359
110 DUODENITIS 107 0.0348
111 ARTERIAL THROMBOSIS 67 0.0346
112 ECCHYMOSIS 236 0.0344
113 LEFT VENTRICULAR DYSFUNCTION 228 0.0340
114 AORTIC ARTERIOSCLEROSIS 86 0.0334
115 HAEMORRHAGE URINARY TRACT 85 0.0334
116 HAEMATURIA 1142 0.0333
117 GASTROINTESTINAL HAEMORRHAGE 2779 0.0332
118 HAEMORRHAGIC STROKE 259 0.0331
119 HEPARIN-INDUCED THROMBOCYTOPENIA 163 0.0330
120 TACHYARRHYTHMIA 82 0.0328
121 URINARY BLADDER HAEMORRHAGE 68 0.0323
122 MYOCARDIAL ISCHAEMIA 365 0.0320
123 MYOPATHY 277 0.0320
124 OESOPHAGEAL PAIN 126 0.0319
125 VITREOUS HAEMORRHAGE 88 0.0318
126 PERIPHERAL ISCHAEMIA 129 0.0316
127 LEFT VENTRICULAR HYPERTROPHY 135 0.0315
128 MYOCARDIAL INFARCTION 5488 0.0314
129 ATRIOVENTRICULAR BLOCK COMPLETE 210 0.0313
130 ATRIOVENTRICULAR BLOCK 242 0.0313
131 CAROTID ARTERY OCCLUSION 113 0.0309
132 IRON DEFICIENCY ANAEMIA 285 0.0308
133 CARDIOGENIC SHOCK 441 0.0307
134 VENTRICULAR FIBRILLATION 340 0.0306
135 ANGIOPATHY 170 0.0303
136 CONJUNCTIVAL HAEMORRHAGE 114 0.0298
137 PLANTAR FASCIITIS 100 0.0298
138 ISCHAEMIC STROKE 530 0.0297
139 EMBOLIC STROKE 104 0.0295
140 MITRAL VALVE INCOMPETENCE 334 0.0295
141 POTENTIATING DRUG INTERACTION 97 0.0289
142 CATHETER SITE HAEMORRHAGE 72 0.0288
143 BLOOD PRESSURE SYSTOLIC ABNORMAL 71 0.0287
144 INTRACARDIAC THROMBUS 88 0.0286
145 VENTRICULAR ARRHYTHMIA 104 0.0284
146 PULSELESS ELECTRICAL ACTIVITY 117 0.0280
147 ARTERIOSPASM CORONARY 112 0.0279
148 LEFT VENTRICULAR FAILURE 96 0.0279
149 RECTAL HAEMORRHAGE 1187 0.0276
150 ASPHYXIA 224 0.0274
151 EUGLYCAEMIC DIABETIC KETOACIDOSIS 113 0.0273
152 LYMPHOEDEMA 189 0.0273
153 CHRONIC KIDNEY DISEASE 2061 0.0271
154 SUFFOCATION FEELING 67 0.0270
155 AORTIC STENOSIS 94 0.0270
156 ABNORMAL LOSS OF WEIGHT 184 0.0270
157 COMA SCALE ABNORMAL 78 0.0269
158 MUSCLE HAEMORRHAGE 108 0.0269
159 HAEMORRHAGE SUBCUTANEOUS 95 0.0268
160 DIVERTICULUM INTESTINAL 117 0.0267
161 POST PROCEDURAL HAEMORRHAGE 311 0.0267
162 GASTRIC ULCER HAEMORRHAGE 148 0.0267
163 OSTEITIS 67 0.0265
164 DRUG INTERACTION 4170 0.0263
165 INCREASED TENDENCY TO BRUISE 241 0.0262
166 LABYRINTHITIS 66 0.0261
167 HEMIPARESIS 442 0.0261
168 RALES 150 0.0258
169 FAECES DISCOLOURED 558 0.0257
170 ARTERIOSCLEROSIS 242 0.0257
171 WOUND HAEMORRHAGE 95 0.0257
172 AORTIC VALVE INCOMPETENCE 109 0.0256
173 ATRIOVENTRICULAR BLOCK FIRST DEGREE 110 0.0254
174 HAEMATOCHEZIA 1399 0.0253
175 EPISTAXIS 1894 0.0253
176 ARTERIOSCLEROSIS CORONARY ARTERY 167 0.0252
177 BUNDLE BRANCH BLOCK LEFT 106 0.0250
178 HAEMOPTYSIS 696 0.0249
179 HAEMORRHAGIC ANAEMIA 109 0.0248
180 COMPARTMENT SYNDROME 64 0.0245
181 EJECTION FRACTION DECREASED 381 0.0245
182 ACUTE KIDNEY INJURY 3749 0.0245
183 TRANSIENT ISCHAEMIC ATTACK 826 0.0245
184 TRICUSPID VALVE INCOMPETENCE 194 0.0244
185 HAEMODYNAMIC INSTABILITY 186 0.0244
186 ATRIOVENTRICULAR BLOCK SECOND DEGREE 74 0.0244
187 HYPOMAGNESAEMIA 338 0.0243
188 MIXED LIVER INJURY 73 0.0242
189 HEPATITIS CHOLESTATIC 146 0.0242
190 ISCHAEMIA 111 0.0241
191 HAEMORRHAGE 2501 0.0239
192 PULMONARY HAEMORRHAGE 186 0.0238
193 SPINAL CORD COMPRESSION 91 0.0233
194 CARDIAC FAILURE ACUTE 153 0.0229
195 VENTRICULAR TACHYCARDIA 378 0.0229
196 ORTHOSTATIC HYPOTENSION 398 0.0228
197 GASTRIC ULCER 430 0.0226
198 ANEURYSM 112 0.0225
199 CIRCULATORY COLLAPSE 381 0.0223
200 DYSPNOEA EXERTIONAL 837 0.0222
201 PERIPHERAL VASCULAR DISORDER 114 0.0221
202 HYPOVOLAEMIC SHOCK 105 0.0219
203 ELECTROCARDIOGRAM ABNORMAL 171 0.0218
204 CONTUSION 2048 0.0213
205 LOSS OF CONTROL OF LEGS 80 0.0211
206 LOOSE TOOTH 68 0.0211
207 BRADYCARDIA 1102 0.0208
208 IMMUNE THROMBOCYTOPENIA 95 0.0207
209 MYOSITIS 186 0.0207
210 DYSLIPIDAEMIA 105 0.0207
211 CEREBRAL INFARCTION 505 0.0206
212 CEREBRAL ISCHAEMIA 106 0.0206
213 GINGIVAL BLEEDING 281 0.0206
214 NON-CARDIAC CHEST PAIN 65 0.0205
215 HEPATIC CYST 69 0.0203
216 HYPERKALAEMIA 708 0.0202
217 HEMIPLEGIA 167 0.0201
218 MUSCLE RUPTURE 78 0.0200
219 HAEMORRHOIDAL HAEMORRHAGE 97 0.0198
220 EXERCISE TOLERANCE DECREASED 114 0.0198
221 MOUTH HAEMORRHAGE 145 0.0198
222 FACIAL PARALYSIS 166 0.0195
223 ANAEMIA 3671 0.0192
224 SUPRAVENTRICULAR EXTRASYSTOLES 65 0.0192
225 INTRACRANIAL ANEURYSM 77 0.0192
226 BENIGN PROSTATIC HYPERPLASIA 99 0.0192
227 PETECHIAE 198 0.0190
228 GLOMERULAR FILTRATION RATE DECREASED 233 0.0189
229 EOSINOPHILIA 332 0.0189
230 PEMPHIGOID 140 0.0185
231 OESOPHAGEAL ULCER 71 0.0184
232 INTERNAL HAEMORRHAGE 208 0.0182
233 BLOOD CHOLESTEROL ABNORMAL 84 0.0182
234 OBSTRUCTIVE AIRWAYS DISORDER 202 0.0181
235 CHEST PAIN 3325 0.0179
236 ANURIA 152 0.0176
237 PROSTATOMEGALY 69 0.0175
238 PALLOR 476 0.0175
239 HAEMOGLOBIN DECREASED 1795 0.0175
240 CARDIAC FAILURE 1401 0.0174
241 MOUTH SWELLING 100 0.0173
242 DIZZINESS POSTURAL 168 0.0173
243 DIVERTICULUM 123 0.0173
244 HIATUS HERNIA 224 0.0173
245 HYDROCEPHALUS 94 0.0172
246 INFLAMMATORY MARKER INCREASED 85 0.0171
247 NEUTROPENIC SEPSIS 122 0.0171
248 SINUS BRADYCARDIA 165 0.0171
249 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 86 0.0170
250 CATHETERISATION CARDIAC 75 0.0169
251 HYPERLIPIDAEMIA 201 0.0168
252 DEVICE OCCLUSION 236 0.0168
253 OESOPHAGITIS 183 0.0167
254 IDIOPATHIC PULMONARY FIBROSIS 66 0.0167
255 HYPONATRAEMIA 931 0.0165
256 GASTRITIS 433 0.0164
257 SLEEP APNOEA SYNDROME 314 0.0164
258 AORTIC ANEURYSM 125 0.0164
259 ACUTE PULMONARY OEDEMA 92 0.0164
260 FEMORAL NECK FRACTURE 84 0.0164
261 VITAMIN B12 DEFICIENCY 66 0.0163
262 PRESYNCOPE 396 0.0163
263 PERICARDIAL EFFUSION 374 0.0162
264 CHOLECYSTITIS ACUTE 91 0.0160
265 GROIN PAIN 141 0.0160
266 BLOOD PRESSURE SYSTOLIC DECREASED 73 0.0160
267 CORONARY ARTERY BYPASS 92 0.0160
268 GOUT 285 0.0159
269 INTESTINAL ISCHAEMIA 87 0.0158
270 ESCHERICHIA URINARY TRACT INFECTION 67 0.0157
271 LARGE INTESTINE POLYP 109 0.0157
272 SYNCOPE 1572 0.0157
273 AORTIC DISSECTION 65 0.0157
274 CARDIAC ARREST 1290 0.0156
275 POLYP 102 0.0156
276 ATRIAL FIBRILLATION 1505 0.0154
277 TORSADE DE POINTES 121 0.0154
278 PURPURA 136 0.0154
279 BLOOD URINE PRESENT 291 0.0153
280 BUNDLE BRANCH BLOCK RIGHT 70 0.0152
281 FAECALOMA 83 0.0151
282 DYSPNOEA 8548 0.0151
283 SKIN ABRASION 71 0.0150
284 CHEST DISCOMFORT 1536 0.0150
285 SUPRAVENTRICULAR TACHYCARDIA 143 0.0149
286 LACTIC ACIDOSIS 483 0.0149
287 EYE HAEMORRHAGE 199 0.0149
288 DRUG-INDUCED LIVER INJURY 466 0.0148
289 CEREBROVASCULAR ACCIDENT 2510 0.0148
290 BLOOD PRESSURE DIASTOLIC DECREASED 109 0.0148
291 SENSATION OF FOREIGN BODY 124 0.0147
292 INTERNATIONAL NORMALISED RATIO INCREASED 415 0.0145
293 UROSEPSIS 134 0.0145
294 SKIN HAEMORRHAGE 214 0.0144
295 ATRIAL FLUTTER 115 0.0144
296 URINE OUTPUT DECREASED 126 0.0144
297 BODY HEIGHT DECREASED 154 0.0144
298 COLITIS MICROSCOPIC 68 0.0143
299 HYPOGLYCAEMIA 696 0.0143
300 GANGRENE 86 0.0143
301 HEART RATE DECREASED 496 0.0141
302 CONTRAINDICATED PRODUCT ADMINISTERED 426 0.0141
303 HYPOTENSION 2811 0.0140
304 EXTRASYSTOLES 97 0.0139
305 ACUTE RESPIRATORY FAILURE 267 0.0139
306 CACHEXIA 71 0.0138
307 RENAL INJURY 409 0.0138
308 ABDOMINAL TENDERNESS 68 0.0137
309 APHASIA 413 0.0137
310 POLYARTHRITIS 72 0.0136
311 RENAL FAILURE 1812 0.0136
312 BLOOD CREATINE PHOSPHOKINASE INCREASED 391 0.0136
313 PRODUCT PRESCRIBING ERROR 323 0.0135
314 RENAL TUBULAR NECROSIS 133 0.0135
315 BLOOD PRESSURE SYSTOLIC INCREASED 264 0.0135
316 HAEMARTHROSIS 121 0.0135
317 ARRHYTHMIA 639 0.0135
318 CHOLESTASIS 259 0.0135
319 VENTRICULAR EXTRASYSTOLES 140 0.0135
320 INCREASED UPPER AIRWAY SECRETION 69 0.0134
321 LOW DENSITY LIPOPROTEIN INCREASED 104 0.0134
322 ELECTROLYTE IMBALANCE 156 0.0134
323 TACHYPNOEA 182 0.0134
324 PERIPHERAL COLDNESS 183 0.0133
325 BLOOD PRESSURE DECREASED 885 0.0133
326 CARDIAC OPERATION 114 0.0132
327 GENERAL PHYSICAL HEALTH DETERIORATION 1529 0.0132
328 BLOOD PRESSURE FLUCTUATION 316 0.0132
329 ULCER HAEMORRHAGE 89 0.0131
330 DRUG RESISTANCE 337 0.0131
331 RESPIRATORY RATE INCREASED 116 0.0131
332 HYPERTENSIVE CRISIS 145 0.0130
333 EXOSTOSIS 118 0.0129
334 TUBULOINTERSTITIAL NEPHRITIS 241 0.0128
335 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 132 0.0128
336 VARICOSE VEIN 66 0.0128
337 HYPOCALCAEMIA 241 0.0127
338 BLOOD POTASSIUM INCREASED 206 0.0127
339 ANAL INCONTINENCE 114 0.0127
340 COAGULOPATHY 211 0.0127
341 BLOOD PRESSURE INADEQUATELY CONTROLLED 76 0.0126
342 DYSARTHRIA 475 0.0126
343 PULMONARY OEDEMA 562 0.0125
344 PRODUCT ADMINISTRATION ERROR 253 0.0125
345 AUTOIMMUNE HEPATITIS 87 0.0125
346 HEAD INJURY 395 0.0125
347 HYPOKALAEMIA 568 0.0123
348 CYSTITIS 389 0.0122
349 SWOLLEN TONGUE 379 0.0121
350 CARDIAC DISORDER 1129 0.0121
351 RENAL CYST 95 0.0119
352 NEUTROPHILIA 68 0.0119
353 BLOOD PRESSURE ABNORMAL 237 0.0119
354 HYPERCHOLESTEROLAEMIA 115 0.0119
355 NEPHROPATHY 111 0.0119
356 PROTHROMBIN TIME PROLONGED 71 0.0119
357 TRANSFUSION 124 0.0118
358 TOXIC SKIN ERUPTION 119 0.0118
359 BLOOD URIC ACID INCREASED 68 0.0118
360 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 612 0.0117
361 HAEMATOCRIT DECREASED 231 0.0116
362 CONFUSIONAL STATE 1871 0.0116
363 METABOLIC ACIDOSIS 370 0.0116
364 DIABETES MELLITUS INADEQUATE CONTROL 204 0.0115
365 MULTIPLE ORGAN DYSFUNCTION SYNDROME 326 0.0115
366 ELECTROCARDIOGRAM QT PROLONGED 412 0.0114
367 HYPOVOLAEMIA 67 0.0114
368 BLOOD CREATININE INCREASED 747 0.0114
369 OLIGURIA 71 0.0114
370 PLATELET COUNT INCREASED 149 0.0114
371 POSTOPERATIVE WOUND INFECTION 77 0.0114
372 EOSINOPHIL COUNT INCREASED 95 0.0114
373 HYPOKINESIA 165 0.0114
374 HALLUCINATION 856 0.0113
375 EMBOLISM 94 0.0113
376 BLOOD UREA INCREASED 189 0.0113
377 NOCTURIA 137 0.0113
378 PRODUCT ODOUR ABNORMAL 118 0.0113
379 HYPERTHYROIDISM 163 0.0112
380 LIP SWELLING 374 0.0112
381 SHOCK 257 0.0112
382 LIVER FUNCTION TEST ABNORMAL 323 0.0111
383 RENAL IMPAIRMENT 930 0.0111
384 PNEUMOTHORAX 175 0.0110
385 PULMONARY HYPERTENSION 229 0.0110
386 FALL 3659 0.0110
387 BLINDNESS TRANSIENT 81 0.0110
388 DRUG ADMINISTRATION ERROR 336 0.0109
389 THROMBOSIS 878 0.0109
390 HEPATITIS ACUTE 70 0.0108
391 MYOCLONUS 128 0.0107
392 RETINAL HAEMORRHAGE 76 0.0107
393 BLOOD CALCIUM DECREASED 119 0.0106
394 CHROMATURIA 238 0.0105
395 URINARY RETENTION 350 0.0105
396 DIARRHOEA HAEMORRHAGIC 98 0.0105
397 CARDIAC FAILURE CONGESTIVE 842 0.0105
398 SPINAL OSTEOARTHRITIS 92 0.0105
399 ANGIOEDEMA 463 0.0105
400 FLANK PAIN 98 0.0104
401 HALLUCINATION, VISUAL 220 0.0104
402 BRONCHOSPASM 148 0.0104
403 HYPERTRANSAMINASAEMIA 72 0.0103
404 HEART RATE IRREGULAR 232 0.0103
405 SKIN ULCER 265 0.0102
406 TOOTH FRACTURE 113 0.0102
407 SECRETION DISCHARGE 128 0.0102
408 BLOOD MAGNESIUM DECREASED 88 0.0102
409 HYPOPHAGIA 260 0.0102
410 BALANCE DISORDER 879 0.0102
411 GASTROOESOPHAGEAL REFLUX DISEASE 815 0.0101
412 UNRESPONSIVE TO STIMULI 261 0.0101
413 RENAL FAILURE ACUTE 429 0.0101
414 OXYGEN SATURATION DECREASED 568 0.0101
415 RESPIRATION ABNORMAL 69 0.0100
416 OEDEMA PERIPHERAL 1216 0.0100
417 COLITIS ISCHAEMIC 67 0.0099
418 MEDICATION ERROR 552 0.0099
419 PLEURAL EFFUSION 604 0.0099
420 CARDIAC FLUTTER 64 0.0099
421 BLOOD TRIGLYCERIDES INCREASED 174 0.0098
422 WOUND 275 0.0098
423 MYALGIA 1669 0.0098
424 SPUTUM DISCOLOURED 93 0.0098
425 MUSCULAR WEAKNESS 1114 0.0098
426 CARDIOVASCULAR DISORDER 248 0.0098
427 COORDINATION ABNORMAL 136 0.0097
428 SKIN LACERATION 106 0.0097
429 JOINT DISLOCATION 103 0.0097
430 DIZZINESS 4857 0.0097
431 BLOOD DISORDER 78 0.0097
432 PRESCRIBED UNDERDOSE 193 0.0097
433 BRAIN OEDEMA 122 0.0096
434 DELIRIUM 335 0.0096
435 CLOSTRIDIUM DIFFICILE COLITIS 102 0.0096
436 ESCHERICHIA INFECTION 79 0.0096
437 ASTHENIA 3609 0.0096
438 FLUID RETENTION 488 0.0096
439 CARDIOMEGALY 118 0.0096
440 COLD SWEAT 168 0.0095
441 ADRENAL INSUFFICIENCY 115 0.0095
442 DYSURIA 348 0.0094
443 INTENTIONAL PRODUCT MISUSE 827 0.0094
444 SENSORY LOSS 76 0.0094
445 HEAD DISCOMFORT 164 0.0093
446 EMPHYSEMA 93 0.0092
447 JAUNDICE 247 0.0092
448 PULMONARY CONGESTION 121 0.0092
449 FIBROMYALGIA 223 0.0092
450 LUNG INFILTRATION 81 0.0092
451 DRUG PRESCRIBING ERROR 176 0.0092
452 THROMBOCYTOPENIA 1016 0.0091
453 BLOOD SODIUM DECREASED 171 0.0091
454 PARKINSONISM 88 0.0090
455 LIVER INJURY 221 0.0090
456 MOUTH ULCERATION 189 0.0090
457 BLOOD PRESSURE INCREASED 1363 0.0089
458 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 229 0.0089
459 HICCUPS 73 0.0089
460 HYPOXIA 311 0.0088
461 PSYCHIATRIC SYMPTOM 65 0.0088
462 LOCALISED INFECTION 212 0.0088
463 AGITATION 643 0.0087
464 APNOEA 68 0.0087
465 LETHARGY 502 0.0087
466 LACERATION 82 0.0087
467 RENAL FAILURE CHRONIC 67 0.0087
468 DECREASED ACTIVITY 94 0.0087
469 DECUBITUS ULCER 71 0.0087
470 DYSPEPSIA 857 0.0087
471 SUDDEN DEATH 92 0.0087
472 BLOOD CHOLESTEROL INCREASED 405 0.0087
473 HYPERTENSION 1835 0.0087
474 HYPERGLYCAEMIA 315 0.0086
475 LEUKOCYTOSIS 156 0.0086
476 TINNITUS 396 0.0086
477 VITAMIN D DEFICIENCY 84 0.0086
478 LOSS OF CONSCIOUSNESS 1102 0.0086
479 BLOOD IRON DECREASED 102 0.0086
480 PRODUCTIVE COUGH 410 0.0086
481 COUGH 2399 0.0085
482 DEMENTIA 239 0.0085
483 RASH MACULO-PAPULAR 190 0.0085
484 SKIN DISCOLOURATION 392 0.0085
485 MUSCULOSKELETAL DISCOMFORT 146 0.0085
486 DEPRESSED LEVEL OF CONSCIOUSNESS 335 0.0085
487 LIMB INJURY 230 0.0085
488 INCONTINENCE 89 0.0084
489 TYPE 2 DIABETES MELLITUS 282 0.0084
490 OSTEOPENIA 127 0.0084
491 PROSTATIC SPECIFIC ANTIGEN INCREASED 115 0.0083
492 TENDON RUPTURE 103 0.0083
493 PERIPHERAL SWELLING 1281 0.0083
494 HAEMORRHOIDS 162 0.0083
495 MUSCULOSKELETAL PAIN 435 0.0083
496 DISORIENTATION 329 0.0083
497 MASS 115 0.0082
498 MALNUTRITION 92 0.0082
499 ERUCTATION 158 0.0082
500 HEPATIC CYTOLYSIS 104 0.0081
501 SCRATCH 86 0.0081
502 DEHYDRATION 1087 0.0081
503 CARDIO-RESPIRATORY ARREST 340 0.0081
504 RESPIRATORY FAILURE 590 0.0081
505 VERTIGO 493 0.0081
506 URINARY INCONTINENCE 239 0.0081
507 CARDIOMYOPATHY 119 0.0080
508 RETINAL DETACHMENT 74 0.0080
509 POLYNEUROPATHY 96 0.0080
510 CHOLECYSTITIS 95 0.0080
511 RIB FRACTURE 164 0.0080
512 GAIT DISTURBANCE 1519 0.0079
513 TASTE DISORDER 161 0.0079
514 IMPAIRED GASTRIC EMPTYING 108 0.0079
515 ABDOMINAL PAIN 1839 0.0079
516 THROMBOTIC MICROANGIOPATHY 77 0.0079
517 TOOTHACHE 143 0.0079
518 PULMONARY FIBROSIS 151 0.0079
519 WEIGHT DECREASED 2189 0.0078
520 BODY TEMPERATURE DECREASED 77 0.0078
521 TENDONITIS 121 0.0078
522 SPEECH DISORDER 408 0.0078
523 SEASONAL ALLERGY 110 0.0078
524 DECREASED APPETITE 1791 0.0077
525 DERMATITIS ALLERGIC 97 0.0077
526 RESPIRATORY DISTRESS 212 0.0077
527 MENTAL STATUS CHANGES 213 0.0077
528 PULMONARY MASS 114 0.0076
529 INABILITY TO AFFORD MEDICATION 76 0.0076
530 GLYCOSYLATED HAEMOGLOBIN INCREASED 193 0.0076
531 HYPOACUSIS 329 0.0076
532 PRURITUS GENERALISED 165 0.0076
533 CARDIAC MURMUR 66 0.0076
534 HAEMODIALYSIS 64 0.0076
535 HYPERHIDROSIS 980 0.0076
536 BLOOD POTASSIUM DECREASED 228 0.0076
537 WHEEZING 449 0.0076
538 CYANOSIS 119 0.0076
539 DYSPHONIA 442 0.0075
540 HEPATOCELLULAR INJURY 107 0.0075
541 SKIN LESION 207 0.0075
542 BASAL CELL CARCINOMA 117 0.0075
543 POLLAKIURIA 312 0.0075
544 DIABETES MELLITUS 570 0.0075
545 GASTROENTERITIS 109 0.0075
546 CLOSTRIDIUM DIFFICILE INFECTION 163 0.0075
547 EATING DISORDER 159 0.0075
548 ABDOMINAL PAIN UPPER 1534 0.0074
549 DRUG LEVEL INCREASED 123 0.0074
550 PHARYNGEAL OEDEMA 114 0.0074
551 SEPSIS 821 0.0074
552 SLUGGISHNESS 75 0.0073
553 PALPITATIONS 861 0.0073
554 PAIN IN EXTREMITY 2164 0.0073
555 MALAISE 3220 0.0073
556 PHARYNGITIS 91 0.0073
557 PNEUMONIA 2362 0.0073
558 BRONCHITIS 540 0.0073
559 DYSSTASIA 213 0.0073
560 MUSCLE TWITCHING 168 0.0073
561 MOTOR DYSFUNCTION 74 0.0073
562 NERVE COMPRESSION 67 0.0073
563 DIVERTICULITIS 201 0.0072
564 MUSCLE SPASMS 1323 0.0072
565 ERYTHEMA MULTIFORME 67 0.0072
566 NECK PAIN 401 0.0072
567 RENAL PAIN 76 0.0072
568 FATIGUE 5578 0.0072
569 DYSPHAGIA 680 0.0072
570 ATAXIA 85 0.0072
571 EYE PAIN 404 0.0072
572 OEDEMA 388 0.0071
573 TACHYCARDIA 634 0.0071
574 IMPAIRED HEALING 234 0.0071
575 MEMORY IMPAIRMENT 979 0.0071
576 SEPTIC SHOCK 310 0.0071
577 DIPLOPIA 185 0.0071
578 TENDERNESS 74 0.0071
579 FEEDING DISORDER 144 0.0071
580 PANCREATITIS ACUTE 159 0.0071
581 RENAL DISORDER 329 0.0071
582 THIRST 126 0.0070
583 NEPHROPATHY TOXIC 79 0.0070
584 COVID-19 PNEUMONIA 83 0.0070
585 INTERSTITIAL LUNG DISEASE 339 0.0070
586 NIGHTMARE 242 0.0070
587 PARALYSIS 100 0.0070
588 WEIGHT FLUCTUATION 73 0.0070
589 ULCER 111 0.0070
590 ERECTILE DYSFUNCTION 179 0.0070
591 CATARACT 415 0.0070
592 WHITE BLOOD CELL COUNT INCREASED 266 0.0069
593 TRANSAMINASES INCREASED 154 0.0069
594 COMA 328 0.0069
595 BRAIN INJURY 69 0.0069
596 URINARY TRACT INFECTION 1173 0.0069
597 RASH GENERALISED 178 0.0069
598 CONSTIPATION 1493 0.0068
599 DEAFNESS 179 0.0068
600 PNEUMONIA ASPIRATION 171 0.0068
601 C-REACTIVE PROTEIN INCREASED 249 0.0068
602 FLATULENCE 388 0.0068
603 SCAB 78 0.0068
604 THERAPY NON-RESPONDER 307 0.0068
605 DISTURBANCE IN ATTENTION 368 0.0068
606 HEPATIC STEATOSIS 127 0.0068
607 AGEUSIA 170 0.0068
608 ABDOMINAL PAIN LOWER 172 0.0068
609 LOWER RESPIRATORY TRACT INFECTION 309 0.0068
610 PHOTOSENSITIVITY REACTION 112 0.0068
611 AGRANULOCYTOSIS 126 0.0068
612 CELLULITIS 341 0.0068
613 LUNG DISORDER 331 0.0067
614 GASTROINTESTINAL PAIN 74 0.0067
615 LIMB DISCOMFORT 208 0.0067
616 HYPOTHERMIA 68 0.0067
617 MULTI-ORGAN FAILURE 116 0.0067
618 PANCYTOPENIA 375 0.0067
619 VASCULITIS 78 0.0067
620 GAIT INABILITY 223 0.0067
621 HEART RATE INCREASED 659 0.0066
622 BACK PAIN 1545 0.0066
623 BLOOD ALKALINE PHOSPHATASE INCREASED 164 0.0066
624 SPLENOMEGALY 77 0.0066
625 OSTEOMYELITIS 119 0.0066
626 DIARRHOEA 4240 0.0066
627 HERNIA 127 0.0066
628 SOPOR 87 0.0066
629 AMNESIA 427 0.0066
630 ALTERED STATE OF CONSCIOUSNESS 142 0.0065
631 FEELING ABNORMAL 1570 0.0065
632 DIABETIC KETOACIDOSIS 157 0.0065
633 HYPERSOMNIA 187 0.0065
634 FEELING COLD 181 0.0065
635 CHOLELITHIASIS 213 0.0065
636 MUSCLE ATROPHY 82 0.0065
637 MOBILITY DECREASED 465 0.0065
638 MUSCULOSKELETAL DISORDER 123 0.0065
639 RESTLESSNESS 236 0.0064
640 BRAIN FOG 101 0.0064
641 ORAL PAIN 144 0.0064
642 NEPHROLITHIASIS 293 0.0064
643 ARTHRITIS 502 0.0064
644 BLINDNESS 260 0.0064
645 DELUSION 99 0.0064
646 PAIN IN JAW 180 0.0063
647 ABDOMINAL DISCOMFORT 1060 0.0063
648 SPINAL PAIN 74 0.0063
649 THERAPY CESSATION 323 0.0063
650 SINUS TACHYCARDIA 89 0.0063
651 VISUAL ACUITY REDUCED 208 0.0063
652 DEPRESSED MOOD 331 0.0063
653 STEVENS-JOHNSON SYNDROME 139 0.0062
654 ALANINE AMINOTRANSFERASE INCREASED 383 0.0062
655 VISION BLURRED 856 0.0062
656 MICTURITION URGENCY 71 0.0062
657 SCIATICA 99 0.0062
658 LIVER FUNCTION TEST INCREASED 133 0.0062
659 OSTEOARTHRITIS 262 0.0062
660 PNEUMONITIS 167 0.0061
661 NODULE 80 0.0061
662 DISSEMINATED INTRAVASCULAR COAGULATION 86 0.0061
663 BLINDNESS UNILATERAL 86 0.0061
664 RED BLOOD CELL COUNT DECREASED 174 0.0061
665 PRODUCT SUBSTITUTION ISSUE 350 0.0061
666 PULMONARY ARTERIAL HYPERTENSION 88 0.0061
667 GENERALISED TONIC-CLONIC SEIZURE 100 0.0060
668 POST PROCEDURAL COMPLICATION 116 0.0060
669 VISUAL IMPAIRMENT 748 0.0060
670 SWELLING FACE 393 0.0060
671 MUCOSAL INFLAMMATION 158 0.0060
672 RASH PRURITIC 327 0.0060
673 CONDITION AGGRAVATED 1830 0.0060
674 JOINT SWELLING 726 0.0060
675 MUSCULOSKELETAL CHEST PAIN 93 0.0060
676 INTERVERTEBRAL DISC PROTRUSION 131 0.0060
677 FLUID OVERLOAD 87 0.0060
678 HIP FRACTURE 192 0.0060
679 PARAESTHESIA 938 0.0060
680 TREATMENT NONCOMPLIANCE 326 0.0060
681 VOMITING 2801 0.0060
682 RESPIRATORY DISORDER 178 0.0059
683 DIALYSIS 84 0.0059
684 DRY MOUTH 480 0.0059
685 SLEEP DISORDER 417 0.0059
686 ABDOMINAL DISTENSION 616 0.0059
687 DRUG DISPENSING ERROR 90 0.0059
688 MOVEMENT DISORDER 189 0.0059
689 BLISTER 330 0.0059
690 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130 0.0059
691 CANDIDA INFECTION 99 0.0059
692 TREMOR 972 0.0059
693 ASPIRATION 64 0.0058
694 DYSKINESIA 237 0.0058
695 RESTLESS LEGS SYNDROME 106 0.0058
696 BURNING SENSATION 408 0.0058
697 ASCITES 171 0.0058
698 MENTAL IMPAIRMENT 141 0.0058
699 HEPATITIS 148 0.0058
700 COLON CANCER 86 0.0058
701 ORAL DISCOMFORT 80 0.0058
702 CHOKING 112 0.0057
703 BONE DISORDER 104 0.0057
704 PRODUCT USE ISSUE 1071 0.0057
705 THINKING ABNORMAL 106 0.0057
706 SOMNOLENCE 1145 0.0057
707 INTENTIONAL PRODUCT USE ISSUE 497 0.0057
708 BACTERIAL INFECTION 105 0.0056
709 SEIZURE 648 0.0056
710 ASPARTATE AMINOTRANSFERASE INCREASED 298 0.0056
711 ACUTE RESPIRATORY DISTRESS SYNDROME 99 0.0056
712 RASH ERYTHEMATOUS 267 0.0056
713 RETCHING 119 0.0056
714 PRODUCT DOSE OMISSION 364 0.0056
715 HYPOAESTHESIA 834 0.0056
716 RHINORRHOEA 359 0.0055
717 COGNITIVE DISORDER 259 0.0055
718 PRURITUS 2130 0.0055
719 QUALITY OF LIFE DECREASED 74 0.0055
720 DEPRESSION 1253 0.0055
721 INTENTIONAL DOSE OMISSION 157 0.0055
722 INSOMNIA 1462 0.0055
723 DRUG DOSE OMISSION 907 0.0055
724 MYELODYSPLASTIC SYNDROME 79 0.0055
725 THYROID DISORDER 84 0.0054
726 TOOTH INFECTION 71 0.0054
727 FEELING HOT 330 0.0054
728 ARTHRALGIA 2235 0.0054
729 RESPIRATORY TRACT INFECTION 140 0.0054
730 NEUROPATHY PERIPHERAL 511 0.0054
731 RASH MACULAR 187 0.0053
732 COLITIS 202 0.0053
733 ROTATOR CUFF SYNDROME 68 0.0053
734 BODY TEMPERATURE INCREASED 108 0.0053
735 HYPOTHYROIDISM 169 0.0053
736 ANAPHYLACTIC REACTION 291 0.0053
737 HEPATOTOXICITY 117 0.0052
738 NAUSEA 4157 0.0052
739 PANIC ATTACK 191 0.0052
740 SPINAL FRACTURE 105 0.0052
741 LUNG INFECTION 81 0.0052
742 ECONOMIC PROBLEM 79 0.0052
743 BLOOD COUNT ABNORMAL 79 0.0052
744 BLOOD GLUCOSE INCREASED 981 0.0052
745 TOXIC EPIDERMAL NECROLYSIS 79 0.0052
746 PARAESTHESIA ORAL 75 0.0052
747 BLOOD TEST ABNORMAL 73 0.0052
748 THROAT IRRITATION 233 0.0052
749 PLATELET COUNT DECREASED 553 0.0052
750 BEDRIDDEN 68 0.0052
751 THERAPY INTERRUPTED 369 0.0052
752 APHONIA 72 0.0052
753 SINUS DISORDER 102 0.0051
754 DRUG ERUPTION 91 0.0051
755 LEUKOPENIA 256 0.0051
756 ANXIETY 1453 0.0051
757 SWELLING 477 0.0051
758 EAR PAIN 99 0.0051
759 GASTROINTESTINAL DISORDER 456 0.0051
760 MIDDLE INSOMNIA 95 0.0051
761 OBESITY 81 0.0051
762 OFF LABEL USE 4440 0.0051
763 NERVOUS SYSTEM DISORDER 158 0.0051
764 NEURALGIA 123 0.0051
765 HEADACHE 3170 0.0051
766 ACTIVITIES OF DAILY LIVING IMPAIRED 100 0.0050
767 GASTRIC DISORDER 173 0.0050
768 FACE OEDEMA 85 0.0050
769 DRUG INTOLERANCE 486 0.0050
770 HOT FLUSH 379 0.0050
771 MUSCLE TIGHTNESS 81 0.0050
772 SARS-COV-2 TEST POSITIVE 66 0.0050
773 DEATH 4305 0.0050
774 SNEEZING 112 0.0050
775 HEPATIC FUNCTION ABNORMAL 186 0.0050
776 EPILEPSY 152 0.0050
777 FRACTURE 94 0.0050
778 ANAPHYLACTIC SHOCK 128 0.0050
779 PROTEINURIA 94 0.0049
780 ABASIA 122 0.0049
781 ORAL CANDIDIASIS 65 0.0049
782 LACRIMATION INCREASED 149 0.0049
783 PARANOIA 85 0.0049
784 INFLAMMATION 254 0.0049
785 COMPLETED SUICIDE 409 0.0049
786 FOOT FRACTURE 93 0.0049
787 NIGHT SWEATS 158 0.0049
788 ACUTE HEPATIC FAILURE 67 0.0049
789 MUSCULOSKELETAL STIFFNESS 429 0.0049
790 BLOOD BILIRUBIN INCREASED 132 0.0049
791 JOINT INJURY 104 0.0049
792 PHOTOPHOBIA 91 0.0048
793 STOMATITIS 293 0.0048
794 COMPLICATION ASSOCIATED WITH DEVICE 70 0.0048
795 PRODUCT PRESCRIBING ISSUE 105 0.0048
796 HEPATIC FAILURE 145 0.0048
797 RESPIRATORY ARREST 132 0.0048
798 LOWER LIMB FRACTURE 92 0.0048
799 FULL BLOOD COUNT DECREASED 96 0.0048
800 NERVOUSNESS 248 0.0047
801 POOR QUALITY SLEEP 102 0.0047
802 INTENTIONAL DRUG MISUSE 99 0.0047
803 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 226 0.0047
804 PULMONARY EMBOLISM 447 0.0047
805 DISCOMFORT 286 0.0047
806 SENSORY DISTURBANCE 75 0.0047
807 GLAUCOMA 90 0.0047
808 BLOOD GLUCOSE DECREASED 224 0.0047
809 URTICARIA 780 0.0047
810 SKIN CANCER 100 0.0046
811 TOOTH DISORDER 103 0.0046
812 OSTEOPOROSIS 190 0.0046
813 BACK DISORDER 75 0.0046
814 RASH 2000 0.0046
815 SEROTONIN SYNDROME 88 0.0046
816 HEPATIC ENZYME INCREASED 311 0.0046
817 SKIN EXFOLIATION 383 0.0045
818 AGGRESSION 227 0.0045
819 KIDNEY INFECTION 89 0.0045
820 ANKLE FRACTURE 70 0.0045
821 CHILLS 530 0.0045
822 EYE SWELLING 168 0.0045
823 HYPOAESTHESIA ORAL 68 0.0045
824 BONE PAIN 261 0.0045
825 PRODUCT USE IN UNAPPROVED INDICATION 1103 0.0044
826 INSURANCE ISSUE 68 0.0044
827 ERYTHEMA 913 0.0044
828 INTESTINAL OBSTRUCTION 167 0.0044
829 FLUSHING 450 0.0044
830 FEAR 119 0.0044
831 PRODUCT DOSE OMISSION IN ERROR 125 0.0044
832 BLOOD GLUCOSE ABNORMAL 81 0.0044
833 EYE DISORDER 144 0.0044
834 SKIN DISORDER 146 0.0044
835 NEUTROPENIA 592 0.0043
836 PAIN 2669 0.0043
837 RESPIRATORY TRACT CONGESTION 69 0.0043
838 HALLUCINATION, AUDITORY 69 0.0043
839 NASOPHARYNGITIS 798 0.0043
840 ENCEPHALOPATHY 106 0.0043
841 PRODUCT DISPENSING ERROR 94 0.0043
842 HEPATIC CIRRHOSIS 81 0.0043
843 ABNORMAL DREAMS 119 0.0043
844 OROPHARYNGEAL PAIN 398 0.0043
845 NEUTROPHIL COUNT DECREASED 174 0.0043
846 ANHEDONIA 112 0.0043
847 THROAT TIGHTNESS 115 0.0042
848 INCREASED APPETITE 81 0.0042
849 HYPERSENSITIVITY 783 0.0042
850 PRODUCT AVAILABILITY ISSUE 96 0.0042
851 GALLBLADDER DISORDER 75 0.0042
852 MULTIPLE FRACTURES 69 0.0042
853 NASAL CONGESTION 246 0.0042
854 COVID-19 732 0.0042
855 INFLUENZA 465 0.0042
856 ILLNESS 429 0.0042
857 HERPES ZOSTER 239 0.0042
858 INFECTION 601 0.0041
859 LIVER DISORDER 184 0.0041
860 DYSGEUSIA 307 0.0041
861 PYREXIA 1421 0.0041
862 ASTHMA 463 0.0041
863 DEEP VEIN THROMBOSIS 265 0.0041
864 GLOSSODYNIA 91 0.0041
865 UPPER RESPIRATORY TRACT INFECTION 187 0.0040
866 LYMPHADENOPATHY 143 0.0040
867 UPPER LIMB FRACTURE 80 0.0040
868 JOINT STIFFNESS 105 0.0040
869 DISEASE RECURRENCE 190 0.0040
870 WEIGHT INCREASED 893 0.0040
871 OCULAR HYPERAEMIA 187 0.0039
872 LABORATORY TEST ABNORMAL 116 0.0039
873 PERICARDITIS 66 0.0039
874 PERITONITIS 81 0.0039
875 DRY EYE 195 0.0039
876 TOXICITY TO VARIOUS AGENTS 657 0.0039
877 GASTROENTERITIS VIRAL 70 0.0039
878 FEMUR FRACTURE 119 0.0038
879 LOCAL SWELLING 67 0.0038
880 SKIN FISSURES 75 0.0038
881 PRESCRIBED OVERDOSE 73 0.0038
882 PRODUCT DOSE OMISSION ISSUE 1102 0.0037
883 ROAD TRAFFIC ACCIDENT 156 0.0037
884 MENTAL DISORDER 162 0.0037
885 ARTHROPATHY 205 0.0037
886 IRRITABLE BOWEL SYNDROME 79 0.0037
887 FREQUENT BOWEL MOVEMENTS 99 0.0037
888 PANCREATITIS 193 0.0036
889 OSTEONECROSIS OF JAW 90 0.0036
890 EYE IRRITATION 208 0.0036
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 196 0.0036
892 ECZEMA 185 0.0035
893 INJECTION SITE BRUISING 282 0.0035
894 MIGRAINE 337 0.0035
895 GYNAECOMASTIA 109 0.0035
896 VIRAL INFECTION 117 0.0035
897 FEBRILE NEUTROPENIA 232 0.0035
898 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 626 0.0035
899 TOOTH LOSS 72 0.0035
900 PSYCHOTIC DISORDER 101 0.0034
901 ANGER 115 0.0034
902 RASH PAPULAR 75 0.0033
903 ACCIDENTAL OVERDOSE 122 0.0033
904 IRRITABILITY 200 0.0033
905 SINUSITIS 340 0.0033
906 STAPHYLOCOCCAL INFECTION 109 0.0033
907 ADVERSE DRUG REACTION 295 0.0033
908 SURGERY 191 0.0033
909 HOSPITALISATION 499 0.0032
910 DEVICE DISLOCATION 141 0.0032
911 UNEVALUABLE EVENT 245 0.0032
912 THERAPEUTIC RESPONSE UNEXPECTED 145 0.0032
913 EAR INFECTION 86 0.0032
914 DRUG INEFFECTIVE 4252 0.0032
915 INJECTION SITE MASS 117 0.0032
916 PAIN OF SKIN 85 0.0032
917 DRUG EFFECT INCOMPLETE 114 0.0031
918 FUNGAL INFECTION 103 0.0031
919 PSORIASIS 402 0.0031
920 INTENTIONAL OVERDOSE 197 0.0031
921 LUNG NEOPLASM MALIGNANT 126 0.0031
922 INFLUENZA LIKE ILLNESS 252 0.0031
923 PSORIATIC ARTHROPATHY 124 0.0031
924 DERMATITIS 64 0.0031
925 ABNORMAL BEHAVIOUR 120 0.0030
926 SEDATION 79 0.0030
927 DISEASE PROGRESSION 355 0.0030
928 SUICIDAL IDEATION 273 0.0030
929 DRY SKIN 397 0.0030
930 ILL-DEFINED DISORDER 180 0.0030
931 ADVERSE EVENT 267 0.0029
932 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 205 0.0029
933 THERAPEUTIC RESPONSE DECREASED 174 0.0029
934 MOOD ALTERED 78 0.0029
935 EYE PRURITUS 95 0.0028
936 RHEUMATOID ARTHRITIS 315 0.0028
937 PROCEDURAL PAIN 76 0.0027
938 DEVICE MALFUNCTION 190 0.0027
939 UNDERDOSE 195 0.0027
940 INJURY 187 0.0027
941 EMOTIONAL DISORDER 82 0.0027
942 SUICIDE ATTEMPT 161 0.0027
943 EXPIRED PRODUCT ADMINISTERED 87 0.0026
944 INFUSION RELATED REACTION 173 0.0026
945 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 528 0.0026
946 WHITE BLOOD CELL COUNT DECREASED 281 0.0026
947 PLASMA CELL MYELOMA 101 0.0026
948 ALOPECIA 506 0.0026
949 THERAPEUTIC RESPONSE SHORTENED 84 0.0025
950 INCORRECT DOSE ADMINISTERED 576 0.0025
951 INJECTION SITE HAEMORRHAGE 199 0.0025
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 83 0.0025
953 VAGINAL HAEMORRHAGE 105 0.0024
954 NEOPLASM MALIGNANT 161 0.0024
955 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
956 THERAPEUTIC PRODUCT EFFECT DECREASED 105 0.0023
957 OVERDOSE 502 0.0023
958 TREATMENT FAILURE 187 0.0023
959 CONVULSION 129 0.0023
960 WITHDRAWAL SYNDROME 93 0.0022
961 PROSTATE CANCER 177 0.0022
962 CRYING 79 0.0022
963 COLITIS ULCERATIVE 94 0.0021
964 PRODUCT QUALITY ISSUE 281 0.0021
965 MALIGNANT NEOPLASM PROGRESSION 208 0.0020
966 NEOPLASM PROGRESSION 70 0.0020
967 EXTRA DOSE ADMINISTERED 79 0.0019
968 SKIN IRRITATION 89 0.0019
969 EMOTIONAL DISTRESS 231 0.0019
970 DEVICE ISSUE 158 0.0018
971 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 124 0.0017
972 SKIN BURNING SENSATION 124 0.0017
973 MULTIPLE SCLEROSIS 79 0.0017
974 INJECTION SITE PAIN 466 0.0015
975 DERMATITIS ATOPIC 74 0.0014
976 DRUG EFFECT DECREASED 73 0.0014
977 NO ADVERSE EVENT 240 0.0013
978 MULTIPLE SCLEROSIS RELAPSE 89 0.0013
979 EXPOSURE DURING PREGNANCY 79 0.0013
980 DEVICE DIFFICULT TO USE 84 0.0013
981 INJECTION SITE SWELLING 96 0.0013
982 ACNE 90 0.0012
983 MATERNAL EXPOSURE DURING PREGNANCY 101 0.0011
984 INJECTION SITE ERYTHEMA 133 0.0011
985 PRODUCT STORAGE ERROR 92 0.0010
986 INJECTION SITE PRURITUS 70 0.0010
987 INJECTION SITE REACTION 71 0.0010
988 DRUG ABUSE 82 0.0010
989 DRUG DOSE OMISSION BY DEVICE 76 0.0010
990 ACCIDENTAL EXPOSURE TO PRODUCT 95 0.0009
991 BREAST CANCER 75 0.0008
992 FOETAL EXPOSURE DURING PREGNANCY 65 0.0008